---

The Office of Cardiology, Hematology, Endocrinology and Nephrology (OCHEN) consists of five review divisions.

• Division of Cardiology and Nephrology (DCN)
• Division of Diabetes, Lipid Disorders and Obesity (DDLO)
• Division of General Endocrinology (DGE)
• Division of Non-Malignant Hematology (DNH)
• Division of Pharmacology/Toxicology or Cardiology, Hematology, Endocrinology and Nephrology (DPT-OCHEN).

The Immediate office oversees the development, review, and regulation of applications for drug and biologic products reviewed in these divisions.

Contact Us

Mailing Address: 

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Cardiology, Hematology, Endocrinology and Nephrology (OCHEN)
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4200
Phone: (301) 796-2270
Fax: (301) 796-9840

Resources 

• Office of New Drugs
• CDER Offices and Divisions
• Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality

---